Instil Bio
TIL50
$66.04arrow_drop_up12.40%$7.29
TIL50
$66.04
arrow_drop_up12.40%Performance History
| Key Stats | |
|---|---|
| Open | $59.10 |
| Prev. Close | $58.75 |
| EPS | -18.39 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 57.99 | 66.45 |
| 52 Week Range | 6.08 | 92.00 |
| Ratios | |
|---|---|
| Revenue | - |
| EBITDA Margin % | - |
| EPS | -18.39 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Instil Bio (TIL)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Bronson Crouch
- Headquarters
- Dallas
- Employees
- 192
- Exchange
- NASDAQ
Keep an eye on Instil Bio
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Instil Bio's (TIL) price per share?
The current price per share for Instil Bio (TIL) is $66.04. The stock has seen a price change of $7.29 recently, indicating a 12.41% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Instil Bio (TIL)?
For Instil Bio (TIL), the 52-week high is $92, which is 39.31% from the current price. The 52-week low is $6.08, the current price is 986.18% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Instil Bio (TIL) a growth stock?
Instil Bio (TIL) has shown an average price growth of 0.41% over the past three years. It has received a score of 99 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Instil Bio as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Instil Bio (TIL) stock price performance year to date (YTD)?
As of the latest data, Instil Bio (TIL) has a year-to-date price change of 749.94%. Over the past month, the stock has experienced a price change of 468.33%. Over the last three months, the change has been 566.4%. Over the past six months, the figure is 440.87%.
help
Is Instil Bio (TIL) a profitable company?
Instil Bio (TIL) has a net income of -$156.09M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$90.54M. Furthermore, the EBITDA is -$66.02M.
help
What is the market capitalization of Instil Bio (TIL)?
Instil Bio (TIL) has a market capitalization of $427.37M. The average daily trading volume is 1.19M, indicating the stock's liquidity and investor engagement.
News
SUMMIT THERAPEUTICS
MERCK
KEYTRUDA
BISPECIFIC ANTIBODY
LUNG CANCER
9/17/2024Here's Why Everyone's Talking About Summit Therapeutics
NON-SMALL CELL LUNG CANCER
TRIPLE-NEGATIVE BREAST CANCER
PD-L1XVEGF BISPECIFIC ANTIBODY
REGISTRATIONAL STRATEGY
CLINICAL TRIALS
9/16/2024Instil Bio and ImmuneOnco Announce Global Registrational Strategy for PD-L1xVEGF Bispecific Antibody, SYN-2510/IMM2510, in Non-Small Cell Lung Cancer and Triple-Negative Breast Cancer
EARNINGS RELEASES AND OPERATING RESULTS
5/10/2024Instil Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
3/27/2024
What Makes Instil Bio (TIL) a New Buy Stock
EARNINGS RELEASES AND OPERATING RESULTS
3/21/2024Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
1/18/2024
Instil (TIL) Stock Rises More Than 20% in a Week: Here's Why